Growth Metrics

Neogenomics (NEO) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to -$9.9 million.

  • Neogenomics' Consolidated Net Income rose 3551.94% to -$9.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$108.0 million, marking a year-over-year decrease of 3721.64%. This contributed to the annual value of -$108.0 million for FY2025, which is 3721.64% down from last year.
  • According to the latest figures from Q4 2025, Neogenomics' Consolidated Net Income is -$9.9 million, which was up 3551.94% from -$27.1 million recorded in Q3 2025.
  • Neogenomics' 5-year Consolidated Net Income high stood at $75.9 million for Q2 2021, and its period low was -$49.4 million during Q1 2022.
  • Its 5-year average for Consolidated Net Income is -$21.4 million, with a median of -$23.5 million in 2022.
  • Examining YoY changes over the last 5 years, Neogenomics' Consolidated Net Income showed a top increase of 121185.52% in 2021 and a maximum decrease of 89577.63% in 2021.
  • Neogenomics' Consolidated Net Income (Quarter) stood at -$41.8 million in 2021, then surged by 45.67% to -$22.7 million in 2022, then skyrocketed by 36.85% to -$14.3 million in 2023, then fell by 6.97% to -$15.3 million in 2024, then skyrocketed by 35.52% to -$9.9 million in 2025.
  • Its Consolidated Net Income stands at -$9.9 million for Q4 2025, versus -$27.1 million for Q3 2025 and -$45.1 million for Q2 2025.